MDPile
SpecialtyNews
RSS icon
MDPile

  • GCCL Enhances Biosimilar Development with New Analysis Methods

    GCCL Enhances Biosimilar Development with New Analysis Methods

    1/22/2025

  • Promising Phase 1 Data for New Cancer Drug HST-1011 Revealed

    Promising Phase 1 Data for New Cancer Drug HST-1011 Revealed

    7/18/2024

  • Innovative Drug BTX-9341 Shows Promise for Advanced Breast Cancer

    Innovative Drug BTX-9341 Shows Promise for Advanced Breast Cancer

    7/18/2024

  • FDA Recognizes Promising New Drug for Rare Lung Cancer

    FDA Recognizes Promising New Drug for Rare Lung Cancer

    7/17/2024

  • New Device Shows Promise in Treating Breast Cancer

    New Device Shows Promise in Treating Breast Cancer

    7/17/2024

  • New Study Urges Longer Lymphedema Monitoring for Breast Cancer Survivors

    New Study Urges Longer Lymphedema Monitoring for Breast Cancer Survivors

    7/17/2024

  • Extended Monitoring Crucial for Breast Cancer Patients to Prevent Lymphedema

    Extended Monitoring Crucial for Breast Cancer Patients to Prevent Lymphedema

    7/17/2024

  • Potential New Hope for Acute Myeloid Leukemia: DSP-5336 Receives FDA Fast Track

    Potential New Hope for Acute Myeloid Leukemia: DSP-5336 Receives FDA Fast Track

    7/16/2024

  • GRAIL's Galleri® Test Shows Promise in Massive Cancer Detection Studies

    GRAIL's Galleri® Test Shows Promise in Massive Cancer Detection Studies

    7/15/2024

  • Breakthrough Cancer Drug Pidnarulex Shows Promise for Patients with Genetic Gene Defects

    Breakthrough Cancer Drug Pidnarulex Shows Promise for Patients with Genetic Gene Defects

    7/12/2024

  • New Dual Inhibitor Shows Promise in Cancer Treatment

    New Dual Inhibitor Shows Promise in Cancer Treatment

    7/11/2024

  • New CMS Proposal to Improve Medicare Payments for Diagnostic Radiopharmaceuticals

    New CMS Proposal to Improve Medicare Payments for Diagnostic Radiopharmaceuticals

    7/11/2024

  • New T-Cell Therapy Research Targets Difficult-to-Treat Leukemia

    New T-Cell Therapy Research Targets Difficult-to-Treat Leukemia

    7/11/2024

  • New Hope for Prostate Cancer: Niclosamide's First Clinical Trial

    New Hope for Prostate Cancer: Niclosamide's First Clinical Trial

    7/11/2024

  • Nusano and PharmaLogic Partner to Enhance Cancer Treatment Options

    Nusano and PharmaLogic Partner to Enhance Cancer Treatment Options

    7/10/2024

  • Significant Survival Boost with New Glioblastoma Drug: Paxalisib

    Significant Survival Boost with New Glioblastoma Drug: Paxalisib

    7/10/2024

  • New Hope for ACC and CRC Patients: FDA Clears Clinical Trial for Innovative Oral Drug

    New Hope for ACC and CRC Patients: FDA Clears Clinical Trial for Innovative Oral Drug

    7/10/2024

  • New Hope for Metastatic Soft Tissue Sarcoma: First Phase 3 Patient Dosed

    New Hope for Metastatic Soft Tissue Sarcoma: First Phase 3 Patient Dosed

    7/9/2024

  • New Trial for Promising Cancer Therapy Gets Green Light from FDA

    New Trial for Promising Cancer Therapy Gets Green Light from FDA

    7/8/2024

  • Promising Results for New Cancer Drug IDE397: A Potential Game-Changer for Urothelial and Lung Cancer

    Promising Results for New Cancer Drug IDE397: A Potential Game-Changer for Urothelial and Lung Cancer

    7/8/2024

  • New Breakthrough: XPOVIO® Approved in China for Treating R/R DLBCL

    New Breakthrough: XPOVIO® Approved in China for Treating R/R DLBCL

    7/8/2024

  • Innovent Takes Big Steps in Sustainability with New ESG Website

    Innovent Takes Big Steps in Sustainability with New ESG Website

    7/8/2024

  • New Cancer Treatment JCXH-211 IV Gets FDA Green Light for Trials

    New Cancer Treatment JCXH-211 IV Gets FDA Green Light for Trials

    7/8/2024

  • FDA Grants Fast Track for Innovative Prostate Cancer Treatment

    FDA Grants Fast Track for Innovative Prostate Cancer Treatment

    7/3/2024

  • Landmark Study Shows CARVYKTI® Improves Survival in Multiple Myeloma Patients

    Landmark Study Shows CARVYKTI® Improves Survival in Multiple Myeloma Patients

    7/2/2024

  • Exciting Advances in Cancer Treatments: Kintara and TuHURA Lead the Way

    Exciting Advances in Cancer Treatments: Kintara and TuHURA Lead the Way

    7/1/2024

  • Breakthrough Results in Pancreatic Cancer Treatment: STP707's Promise

    Breakthrough Results in Pancreatic Cancer Treatment: STP707's Promise

    6/28/2024

  • New Advances in Metastatic Breast Cancer: Positive FDA Meeting for Oncolytics Biotech's Pelareorep

    New Advances in Metastatic Breast Cancer: Positive FDA Meeting for Oncolytics Biotech's Pelareorep

    6/27/2024

  • Breakthrough in Clinical Trials: Atreo Simplifies Precision Medicine with New RTSM Features

    Breakthrough in Clinical Trials: Atreo Simplifies Precision Medicine with New RTSM Features

    6/27/2024

  • New Advances in Pediatric Brain Cancer: Breaking Down Kazia's Latest Findings

    New Advances in Pediatric Brain Cancer: Breaking Down Kazia's Latest Findings

    6/27/2024

  • New Hope for Relapsed Follicular Lymphoma: EPKINLY Receives FDA Approval

    New Hope for Relapsed Follicular Lymphoma: EPKINLY Receives FDA Approval

    6/27/2024

  • New Hope for Gastric Cancer Patients: EO-3021 Shows Promise in Combination Therapy

    New Hope for Gastric Cancer Patients: EO-3021 Shows Promise in Combination Therapy

    6/27/2024

  • New Combination Therapy Shows Hope for Advanced Liver Cancer Patients

    New Combination Therapy Shows Hope for Advanced Liver Cancer Patients

    6/27/2024

  • LENVIMA Shows Promise in Liver Cancer: Key Findings from the REFLECT Trial

    LENVIMA Shows Promise in Liver Cancer: Key Findings from the REFLECT Trial

    6/27/2024

  • Revolutionizing Clinical Trials with Suvoda's ePatient App

    Revolutionizing Clinical Trials with Suvoda's ePatient App

    6/27/2024

  • Revolutionizing Orthopedic Surgery: How 3D Printing is Transforming Tumor Removal

    Revolutionizing Orthopedic Surgery: How 3D Printing is Transforming Tumor Removal

    6/27/2024

  • New Hope for HER2-Positive Breast Cancer Treatment with HVH-2930

    New Hope for HER2-Positive Breast Cancer Treatment with HVH-2930

    6/27/2024

  • New Genomic Test Revolutionizes DCIS Treatment Decisions

    New Genomic Test Revolutionizes DCIS Treatment Decisions

    6/26/2024

  • New Clinical Trial: Combining IDE397 and Trodelvy to Fight Bladder Cancer

    New Clinical Trial: Combining IDE397 and Trodelvy to Fight Bladder Cancer

    6/25/2024

  • Enhancing Clinical Trials: How SitePlus Revolutionizes Patient Recruitment and Retention

    Enhancing Clinical Trials: How SitePlus Revolutionizes Patient Recruitment and Retention

    6/25/2024

  • FDA Fast Track Approval: A Ray of Hope for HER2-Positive Tumor Patients

    FDA Fast Track Approval: A Ray of Hope for HER2-Positive Tumor Patients

    6/25/2024

  • New Advancements in Immunotherapy for Advanced Ovarian Cancer

    New Advancements in Immunotherapy for Advanced Ovarian Cancer

    6/24/2024

  • Innovative CAR-T Therapy Shows Promise in Fighting Ovarian Cancer

    Innovative CAR-T Therapy Shows Promise in Fighting Ovarian Cancer

    6/24/2024

  • Arvinas' New Hope for Lymphoma and Neurodegeneration: PROTAC Degraders

    Arvinas' New Hope for Lymphoma and Neurodegeneration: PROTAC Degraders

    6/21/2024

  • Promising New Treatment for Multiple Myeloma Shows High Success Rate

    Promising New Treatment for Multiple Myeloma Shows High Success Rate

    6/21/2024

  • New Drug Combination Offers Hope for Difficult-to-Treat Lymphoma

    New Drug Combination Offers Hope for Difficult-to-Treat Lymphoma

    6/19/2024

  • Breakthroughs in Cancer Treatment Unveiled at ASCO 2024

    Breakthroughs in Cancer Treatment Unveiled at ASCO 2024

    6/19/2024

  • Breakthrough Treatment for Relapsed T-Cell Lymphoma Approved in China

    Breakthrough Treatment for Relapsed T-Cell Lymphoma Approved in China

    6/19/2024

  • DAY301: A New Hope for Cancer Patients of All Ages

    DAY301: A New Hope for Cancer Patients of All Ages

    6/18/2024

  • Breakthrough Hemopurifier® Study in Cancer Patients Gets Green Light

    Breakthrough Hemopurifier® Study in Cancer Patients Gets Green Light

    6/18/2024

  • Roche's Innovative Digital Pathology Solution Gains FDA Approval

    Roche's Innovative Digital Pathology Solution Gains FDA Approval

    6/18/2024

  • Promising Results in Leukemia Trial: New Hope for AML Patients

    Promising Results in Leukemia Trial: New Hope for AML Patients

    6/17/2024

  • Promising New CAR-T Therapy Targets Hard-to-Treat Multiple Myeloma

    Promising New CAR-T Therapy Targets Hard-to-Treat Multiple Myeloma

    6/15/2024

  • Takeda Joins Forces with Ascentage Pharma to Target Drug-Resistant Leukemia

    Takeda Joins Forces with Ascentage Pharma to Target Drug-Resistant Leukemia

    6/15/2024

  • FDA Greenlights Breakthrough Treatment for Aggressive Blood Cancer

    FDA Greenlights Breakthrough Treatment for Aggressive Blood Cancer

    6/15/2024

  • New Hope for Colon Cancer Patients: LIXTE's Innovative Trial with Roche and NKI

    New Hope for Colon Cancer Patients: LIXTE's Innovative Trial with Roche and NKI

    6/14/2024

  • New Findings Highlight Earlier Use of Yescarta for Better Outcomes in Blood Cancer Treatment

    New Findings Highlight Earlier Use of Yescarta for Better Outcomes in Blood Cancer Treatment

    6/14/2024

  • Innovent's New Breakthrough in Fighting Advanced Lung Cancer: A Closer Look at IBI363

    Innovent's New Breakthrough in Fighting Advanced Lung Cancer: A Closer Look at IBI363

    6/14/2024

  • FDA Approves New Treatment for NTRK Gene Fusion-Positive Tumors

    FDA Approves New Treatment for NTRK Gene Fusion-Positive Tumors

    6/13/2024

  • Innovative Cancer Treatment: Oligonucleotide-ChemoDrug Conjugates Show Promising Results

    Innovative Cancer Treatment: Oligonucleotide-ChemoDrug Conjugates Show Promising Results

    6/13/2024

  • Innovative Nanotherapy Shows Promise in Treating Head and Neck Cancer

    Innovative Nanotherapy Shows Promise in Treating Head and Neck Cancer

    6/12/2024

  • Breakthrough in Cancer Treatment: NKGen's SNK02 Shows Promising Results

    Breakthrough in Cancer Treatment: NKGen's SNK02 Shows Promising Results

    6/12/2024

  • Revolutionizing Lung Cancer Treatment: Key Insights from Leading Oncologists

    Revolutionizing Lung Cancer Treatment: Key Insights from Leading Oncologists

    6/12/2024

  • Innovative Treatments for Non-Small Cell Lung Cancer: A New Hope

    Innovative Treatments for Non-Small Cell Lung Cancer: A New Hope

    6/12/2024

  • Revolutionary Technique Unmasks Early DNA Mutations

    Revolutionary Technique Unmasks Early DNA Mutations

    6/12/2024

  • AI-Driven Tool Transforming Lung Cancer Diagnosis and Prognosis

    AI-Driven Tool Transforming Lung Cancer Diagnosis and Prognosis

    6/11/2024

  • Revolutionary AI Technology Enhances Prostate Cancer Detection

    Revolutionary AI Technology Enhances Prostate Cancer Detection

    6/11/2024

  • Breakthrough in Leukemia Treatment: Eilean Therapeutics Joins Beat AML® Trial

    Breakthrough in Leukemia Treatment: Eilean Therapeutics Joins Beat AML® Trial

    6/11/2024

  • Breakthrough in Lung Cancer Treatment: TAGRISSO® Receives Priority Review

    Breakthrough in Lung Cancer Treatment: TAGRISSO® Receives Priority Review

    6/10/2024

  • Groundbreaking Treatment for Acute Myeloid Leukemia Gets FDA Green Light

    Groundbreaking Treatment for Acute Myeloid Leukemia Gets FDA Green Light

    6/10/2024

  • Revolutionizing Clinical Trials: Cloud Concinnity's Latest Update Enhances Efficiency

    Revolutionizing Clinical Trials: Cloud Concinnity's Latest Update Enhances Efficiency

    6/7/2024

  • Revolutionizing Clinical Trials with Cloud Concinnity 3.2.0

    Revolutionizing Clinical Trials with Cloud Concinnity 3.2.0

    6/7/2024

  • New Partnership Aims to Transform Cancer Treatment in Asia

    New Partnership Aims to Transform Cancer Treatment in Asia

    6/7/2024

  • New Treatment Shows Promise for Ovarian Cancer Patients

    New Treatment Shows Promise for Ovarian Cancer Patients

    6/6/2024

  • Promising New Teclistamab Combo Therapy for Myeloma Shows Early Success

    Promising New Teclistamab Combo Therapy for Myeloma Shows Early Success

    6/6/2024

  • New Therapy Shows Promise in Fighting Bladder Cancer

    New Therapy Shows Promise in Fighting Bladder Cancer

    6/6/2024

  • Ovarian Cancer: Mirvetuximab Soravtansine Shows Promising Results

    Ovarian Cancer: Mirvetuximab Soravtansine Shows Promising Results

    6/6/2024

  • New Treatment Shows Promise for Advanced Colorectal Cancer

    New Treatment Shows Promise for Advanced Colorectal Cancer

    6/6/2024

  • How Gene Profiles Affect Kidney Cancer Treatments

    How Gene Profiles Affect Kidney Cancer Treatments

    6/5/2024

  • Empowering Cannabis Research: Vita Biotech Partners with CBIH

    Empowering Cannabis Research: Vita Biotech Partners with CBIH

    6/5/2024

  • Daratumumab: A Promising Retreatment Option for Myeloma Patients

    Daratumumab: A Promising Retreatment Option for Myeloma Patients

    6/5/2024

  • Acute Lymphoblastic Leukemia Patients with UCART22 Therapy

    Acute Lymphoblastic Leukemia Patients with UCART22 Therapy

    6/5/2024

  • FDA Fast Tracks New Treatment for Tough-to-Treat Ovarian Cancer

    FDA Fast Tracks New Treatment for Tough-to-Treat Ovarian Cancer

    6/5/2024

  • Liver Transplants Boost Survival Rates for Advanced Colorectal Cancer Patients

    Liver Transplants Boost Survival Rates for Advanced Colorectal Cancer Patients

    6/5/2024

  • Innovative Cancer Treatments from RemeGen: Highlights from ASCO 2024

    Innovative Cancer Treatments from RemeGen: Highlights from ASCO 2024

    6/5/2024

  • Revolutionary Partnership Achieves Breakthrough in Cancer Treatment

    Revolutionary Partnership Achieves Breakthrough in Cancer Treatment

    6/4/2024

  • Promising Therapy for HPV-Related Head and Neck Cancer Shows Strong Results

    Promising Therapy for HPV-Related Head and Neck Cancer Shows Strong Results

    6/4/2024

  • Innovative AI Tool Enhances Cancer Immunotherapy Predictions

    Innovative AI Tool Enhances Cancer Immunotherapy Predictions

    6/4/2024

  • Promising New Antibody-Drug Conjugate Shows Potential for Treating Advanced Solid Tumors

    Promising New Antibody-Drug Conjugate Shows Potential for Treating Advanced Solid Tumors

    6/4/2024

  • Cancer Treatment: RC88 Shows Promising Results in Early Clinical Trials

    Cancer Treatment: RC88 Shows Promising Results in Early Clinical Trials

    6/4/2024

  • New Study Unveils Hope for EGFR-Mutated Lung Cancer with Easier Treatment

    New Study Unveils Hope for EGFR-Mutated Lung Cancer with Easier Treatment

    6/3/2024

  • New Advances in EGFR-Mutated Lung Cancer Treatment Show Promising Results

    New Advances in EGFR-Mutated Lung Cancer Treatment Show Promising Results

    6/3/2024

  • Revolutionizing Cancer Trials: New Strategies for Better Patient Enrollment

    Revolutionizing Cancer Trials: New Strategies for Better Patient Enrollment

    6/3/2024

  • Groundbreaking Updates on Melanoma and Advanced Endometrial Cancer from NYU Langone at ASCO 2024

    Groundbreaking Updates on Melanoma and Advanced Endometrial Cancer from NYU Langone at ASCO 2024

    6/3/2024

  • Revolutionizing Cancer Treatment: How AI is Powering the Next Wave of Antibody Therapies

    Revolutionizing Cancer Treatment: How AI is Powering the Next Wave of Antibody Therapies

    6/3/2024

  • New AI Blood Test Revolutionizes Early Lung Cancer Detection

    New AI Blood Test Revolutionizes Early Lung Cancer Detection

    6/3/2024

  • Revolutionary IRO® Platform Enhances Cell and Gene Therapy Manufacturing

    Revolutionary IRO® Platform Enhances Cell and Gene Therapy Manufacturing

    6/3/2024

  • Breakthrough in Cancer Treatment: Minghui's Promising MHB088C Shows Positive Results

    Breakthrough in Cancer Treatment: Minghui's Promising MHB088C Shows Positive Results

    6/3/2024

  • Scientific Breakthroughs: Innovations to Combat Pancreatic Cancer

    Scientific Breakthroughs: Innovations to Combat Pancreatic Cancer

    6/3/2024

  • Groundbreaking T-Cell Platform Shows Promise in Combating Various Cancers

    Groundbreaking T-Cell Platform Shows Promise in Combating Various Cancers

    6/3/2024

  • New Personalized Cancer Vaccine Shows Promise in Advanced Skin Cancer Treatment

    New Personalized Cancer Vaccine Shows Promise in Advanced Skin Cancer Treatment

    6/3/2024

  • Breakthrough in NK Cell Therapy for Advanced Solid Tumors

    Breakthrough in NK Cell Therapy for Advanced Solid Tumors

    6/3/2024

  • Promising Results from Anti-HER2 Therapy JSKN003

    Promising Results from Anti-HER2 Therapy JSKN003

    6/3/2024

  • New Hope for Cancer Patients: Preliminary Trials for Hemopurifier® Begin

    New Hope for Cancer Patients: Preliminary Trials for Hemopurifier® Begin

    6/3/2024

  • Telix Pharmaceuticals' Pioneering Imaging Agent for Kidney Cancer Nears FDA Approval

    Telix Pharmaceuticals' Pioneering Imaging Agent for Kidney Cancer Nears FDA Approval

    6/2/2024

  • Neoadjuvant Immunotherapy: A Breakthrough for Stage III Melanoma Treatment

    Neoadjuvant Immunotherapy: A Breakthrough for Stage III Melanoma Treatment

    6/2/2024

  • Breakthrough in Early Cancer Detection: Largest Proteomics Study Completed

    Breakthrough in Early Cancer Detection: Largest Proteomics Study Completed

    6/2/2024

  • Breakthrough in Reducing Side Effects of Advanced Breast Cancer Treatment

    Breakthrough in Reducing Side Effects of Advanced Breast Cancer Treatment

    6/2/2024

  • Promising New Cancer Therapy Shows Potential in Head and Neck Cancer Patients

    Promising New Cancer Therapy Shows Potential in Head and Neck Cancer Patients

    6/2/2024

  • Innovent's Breakthrough in Lung Cancer Treatment: Taletrectinib Shows Promise

    Innovent's Breakthrough in Lung Cancer Treatment: Taletrectinib Shows Promise

    6/2/2024

  • Head and Neck Cancer: Exciting Phase II Trial Highlights Combination Therapy

    Head and Neck Cancer: Exciting Phase II Trial Highlights Combination Therapy

    6/2/2024

  • Promising Advances in Lung Cancer Treatment with AFM24 and Atezolizumab

    Promising Advances in Lung Cancer Treatment with AFM24 and Atezolizumab

    6/2/2024

  • Breakthrough in Lung Cancer Treatment: European Approval Expected for Sugemalimab

    Breakthrough in Lung Cancer Treatment: European Approval Expected for Sugemalimab

    6/2/2024

  • Groundbreaking Advances in Lung Cancer Treatment: New Combo Therapy Shows Promise

    Groundbreaking Advances in Lung Cancer Treatment: New Combo Therapy Shows Promise

    6/2/2024

  • Zanidatamab Shows Hopeful Results for Treating HER2-Positive Biliary Tract Cancer

    Zanidatamab Shows Hopeful Results for Treating HER2-Positive Biliary Tract Cancer

    6/2/2024

  • Promising Results for New Cancer Therapy Combo in Lung Cancer Treatment

    Promising Results for New Cancer Therapy Combo in Lung Cancer Treatment

    6/1/2024

  • Breakthrough Treatment Zanidatamab Shows Promise for Advanced Biliary Tract Cancer

    Breakthrough Treatment Zanidatamab Shows Promise for Advanced Biliary Tract Cancer

    6/1/2024

  • New Subcutaneous Injection for Lung Cancer Patients Shows Promising Results

    New Subcutaneous Injection for Lung Cancer Patients Shows Promising Results

    5/31/2024

  • Innovative Assay for Tracking Cancer Therapy Progress

    Innovative Assay for Tracking Cancer Therapy Progress

    5/31/2024

  • New Hope for Cancer Patients: MDNA11 Shows Promising Results in Clinical Trials

    New Hope for Cancer Patients: MDNA11 Shows Promising Results in Clinical Trials

    5/31/2024

  • Strategic Partnership Aims to Make Advanced Cancer Therapy Accessible in China

    Strategic Partnership Aims to Make Advanced Cancer Therapy Accessible in China

    5/31/2024

  • Revolutionizing Cancer Treatment: Kinomica's KScan® Shows Promising Results

    Revolutionizing Cancer Treatment: Kinomica's KScan® Shows Promising Results

    5/31/2024

  • New Hope for Advanced Stomach Cancer: FDA Reviews Innovative Treatment

    New Hope for Advanced Stomach Cancer: FDA Reviews Innovative Treatment

    5/31/2024

  • New Hope for Advanced Prostate Cancer: SYNC-T SV-102 Immunotherapy Approved by FDA

    New Hope for Advanced Prostate Cancer: SYNC-T SV-102 Immunotherapy Approved by FDA

    5/31/2024

  • New Prostate Cancer Treatment Shows Promising Results in Early Trials

    New Prostate Cancer Treatment Shows Promising Results in Early Trials

    5/31/2024

  • Breakthrough in Lung Cancer Treatment: Ivonescimab Outshines Pembrolizumab

    Breakthrough in Lung Cancer Treatment: Ivonescimab Outshines Pembrolizumab

    5/30/2024

  • New Immunotherapy Ivonescimab Shows Significant PFS Improvement in Lung Cancer Patients

    New Immunotherapy Ivonescimab Shows Significant PFS Improvement in Lung Cancer Patients

    5/30/2024

  • Revolutionary Nanodrug AGuIX Gains FDA Fast Track Approval for Brain Cancer Treatment

    Revolutionary Nanodrug AGuIX Gains FDA Fast Track Approval for Brain Cancer Treatment

    5/30/2024

  • Innovative Cancer Treatment Shows Promise in Clinical Trials

    Innovative Cancer Treatment Shows Promise in Clinical Trials

    5/30/2024

  • Revolutionizing Cancer Treatment: The Breakthrough QPOR™ Platform

    Revolutionizing Cancer Treatment: The Breakthrough QPOR™ Platform

    5/30/2024

  • Mereo BioPharma Discusses Groundbreaking Therapies for Rare Diseases at Global Healthcare Forum

    Mereo BioPharma Discusses Groundbreaking Therapies for Rare Diseases at Global Healthcare Forum

    5/30/2024

  • Breakthrough Radiotherapy for Advanced Prostate Cancer Cleared for Clinical Trials

    Breakthrough Radiotherapy for Advanced Prostate Cancer Cleared for Clinical Trials

    5/30/2024

  • Advanced Breast Cancer Patients: FDA Fast-Tracks Inavolisib Combo

    Advanced Breast Cancer Patients: FDA Fast-Tracks Inavolisib Combo

    5/29/2024

  • Esophageal Cancer Patients: Immune Therapy Shows Promise

    Esophageal Cancer Patients: Immune Therapy Shows Promise

    5/29/2024

  • New Advances in Cell and Gene Therapy Manufacturing: Ori Biotech’s IRO Platform Revealed

    New Advances in Cell and Gene Therapy Manufacturing: Ori Biotech’s IRO Platform Revealed

    5/29/2024

  • Kids with Rare Thyroid Cancers: Selpercatinib's Accelerated Approval

    Kids with Rare Thyroid Cancers: Selpercatinib's Accelerated Approval

    5/29/2024

  • Promising New Treatment Gains FDA Fast Track for Tough Lung Cancer Cases

    Promising New Treatment Gains FDA Fast Track for Tough Lung Cancer Cases

    5/29/2024

  • Promising Combo Therapy for Treating Advanced Pleural Mesothelioma

    Promising Combo Therapy for Treating Advanced Pleural Mesothelioma

    5/29/2024

  • Advanced Bladder Cancer: Nivolumab Plus Chemotherapy Gains Approval in Europe

    Advanced Bladder Cancer: Nivolumab Plus Chemotherapy Gains Approval in Europe

    5/29/2024

  • Promising New Combo Therapy Nears Approval for Advanced Breast Cancer

    Promising New Combo Therapy Nears Approval for Advanced Breast Cancer

    5/29/2024

  • Expanding Cancer Clinical Trials Access in Rural Communities: A Success Story

    Expanding Cancer Clinical Trials Access in Rural Communities: A Success Story

    5/29/2024

  • Promising Results for Nivolumab and Cabozantinib Combo in Treating Non-Clear Cell Kidney Cancer

    Promising Results for Nivolumab and Cabozantinib Combo in Treating Non-Clear Cell Kidney Cancer

    5/29/2024

  • Breakthrough in Metastatic Cancer Treatment: Promising Results from TransCode Therapeutics' TTX-MC138

    Breakthrough in Metastatic Cancer Treatment: Promising Results from TransCode Therapeutics' TTX-MC138

    5/29/2024

  • Radiation Therapy Breakthroughs Revolutionize Lung Cancer Treatment

    Radiation Therapy Breakthroughs Revolutionize Lung Cancer Treatment

    5/29/2024

  • Pancreatic Cancer: CT041 Shows Promise in Treatment

    Pancreatic Cancer: CT041 Shows Promise in Treatment

    5/29/2024

  • Promising Advances in CBD Co-Crystal Research for Disease Treatment

    Promising Advances in CBD Co-Crystal Research for Disease Treatment

    5/29/2024

  • New Hope for Ovarian Cancer Screening in Postmenopausal Women

    New Hope for Ovarian Cancer Screening in Postmenopausal Women

    5/29/2024

  • Revolutionary Ovarian Cancer Screening Test Gains FDA Breakthrough Status

    Revolutionary Ovarian Cancer Screening Test Gains FDA Breakthrough Status

    5/29/2024

  • The Role of LYMPHA in Reducing Complications Post-Mastectomy

    The Role of LYMPHA in Reducing Complications Post-Mastectomy

    5/29/2024

  • Biohaven Advances New Cancer Drug into Clinical Trials for Hard-to-Treat Tumors

    Biohaven Advances New Cancer Drug into Clinical Trials for Hard-to-Treat Tumors

    5/29/2024

  • Innovative Cancer Therapy Shows Promise: First Data on GRWD5769 to be Revealed at ASCO 2024

    Innovative Cancer Therapy Shows Promise: First Data on GRWD5769 to be Revealed at ASCO 2024

    5/29/2024

  • How CDMOs Are Revolutionizing Biologics Manufacturing

    How CDMOs Are Revolutionizing Biologics Manufacturing

    5/29/2024

  • Revolutionizing Cancer Care: How CancerLinQ's Innovations Improve Patient Outcomes

    Revolutionizing Cancer Care: How CancerLinQ's Innovations Improve Patient Outcomes

    5/28/2024

  • New Strategies in Treating CLL: Navigating BTK Inhibitor Progression

    New Strategies in Treating CLL: Navigating BTK Inhibitor Progression

    5/28/2024

  • Ikena Oncology Shifts Focus: Key Updates on Cancer Research

    Ikena Oncology Shifts Focus: Key Updates on Cancer Research

    5/28/2024

  • Safe Fertility Treatments for Women with BRCA-Mutated Breast Cancer: A Breakthrough Discovery

    Safe Fertility Treatments for Women with BRCA-Mutated Breast Cancer: A Breakthrough Discovery

    5/28/2024

  • New Oral Treatment for Pediatric Brain Tumors: Tovorafenib Shows Promising Results

    New Oral Treatment for Pediatric Brain Tumors: Tovorafenib Shows Promising Results

    5/28/2024

  • Breaking New Ground: Dato-DXd Extends Survival in Advanced Lung Cancer

    Breaking New Ground: Dato-DXd Extends Survival in Advanced Lung Cancer

    5/28/2024

  • The Significance of Identifying Brain Metastases in Prostate Cancer Patients

    The Significance of Identifying Brain Metastases in Prostate Cancer Patients

    5/28/2024

  • Ipsen Outlines Future Strategies and Commitments at Annual General Meeting

    Ipsen Outlines Future Strategies and Commitments at Annual General Meeting

    5/28/2024

  • New Hope for Patients with Multiple Myeloma: FDA Prioritizes Isatuximab Combo

    New Hope for Patients with Multiple Myeloma: FDA Prioritizes Isatuximab Combo

    5/28/2024

  • New Treatment for High-Risk Early Triple-Negative Breast Cancer Shows Promising Results

    New Treatment for High-Risk Early Triple-Negative Breast Cancer Shows Promising Results

    5/28/2024

  • Understanding IntelGenx: Restructuring and Future Prospects

    Understanding IntelGenx: Restructuring and Future Prospects

    5/28/2024

  • Groundbreaking Collaboration to Advance Lung Cancer Treatment

    Groundbreaking Collaboration to Advance Lung Cancer Treatment

    5/28/2024

  • How Proton Beam Therapy is Revolutionizing Lung Cancer Treatment

    How Proton Beam Therapy is Revolutionizing Lung Cancer Treatment

    5/28/2024

  • Exciting Advancements in Multiple Myeloma Treatment Offer New Hope

    Exciting Advancements in Multiple Myeloma Treatment Offer New Hope

    5/28/2024

  • Exciting Advances in Oncology: Amgen's Groundbreaking Research at ASCO 2024

    Exciting Advances in Oncology: Amgen's Groundbreaking Research at ASCO 2024

    5/28/2024

  • PCSK9: A New Hope in the Fight Against Skin Melanoma

    PCSK9: A New Hope in the Fight Against Skin Melanoma

    5/28/2024

  • Understanding the Influence of Genetic Testing on Breast Cancer Surgery Choices

    Understanding the Influence of Genetic Testing on Breast Cancer Surgery Choices

    5/28/2024

  • New Hope for Multiple Myeloma Patients: Isatuximab Combo Shows Promise

    New Hope for Multiple Myeloma Patients: Isatuximab Combo Shows Promise

    5/27/2024

  • Revolutionizing Lung Cancer Treatment: The Power of Combining Immunotherapy with Radiation

    Revolutionizing Lung Cancer Treatment: The Power of Combining Immunotherapy with Radiation

    5/27/2024

  • Breakthrough Whole Genome Sequencing Enhances Treatment for AML and MDS

    Breakthrough Whole Genome Sequencing Enhances Treatment for AML and MDS

    5/27/2024

  • Revolutionary CAR T-Cell Therapy Transforms Chronic Lymphocytic Leukemia Treatment

    Revolutionary CAR T-Cell Therapy Transforms Chronic Lymphocytic Leukemia Treatment

    5/26/2024

  • Revolutionizing Cancer Treatment: AI Innovations Presented at ASCO 2024

    Revolutionizing Cancer Treatment: AI Innovations Presented at ASCO 2024

    5/24/2024

  • New Hope for Ovarian Cancer: Promising Results of GC203 Therapy

    New Hope for Ovarian Cancer: Promising Results of GC203 Therapy

    5/24/2024

  • Groundbreaking Genetic Testing Advances Unveiled at Key Cancer Research Meeting

    Groundbreaking Genetic Testing Advances Unveiled at Key Cancer Research Meeting

    5/24/2024

  • Exciting Advances in Rare Tumor Treatments Unveiled at ASCO 2024

    Exciting Advances in Rare Tumor Treatments Unveiled at ASCO 2024

    5/24/2024

  • Groundbreaking Cancer Treatment AdAPT-001 Shows Promise at ASCO 2024

    Groundbreaking Cancer Treatment AdAPT-001 Shows Promise at ASCO 2024

    5/23/2024

  • Promising Approach to Save Vision in Uveal Melanoma Patients with New Drug

    Promising Approach to Save Vision in Uveal Melanoma Patients with New Drug

    5/23/2024

  • Groundbreaking Results from BLU-222 Trial Inspire Renewed Hope in Breast Cancer Treatment

    Groundbreaking Results from BLU-222 Trial Inspire Renewed Hope in Breast Cancer Treatment

    5/23/2024

  • Breakthrough Ovarian Cancer Test Shows Unmatched Accuracy

    Breakthrough Ovarian Cancer Test Shows Unmatched Accuracy

    5/23/2024

  • Promising CAR-NKT Therapy Sheds New Hope for Kidney Cancer Battles

    Promising CAR-NKT Therapy Sheds New Hope for Kidney Cancer Battles

    5/23/2024

  • Lilly's Latest Cancer Treatments to be Showcased at ASCO 2024

    Lilly's Latest Cancer Treatments to be Showcased at ASCO 2024

    5/23/2024

  • VCN-01: A Promising New Approach for Advanced Pancreatic Cancer

    VCN-01: A Promising New Approach for Advanced Pancreatic Cancer

    5/23/2024

  • Eisai Unveils Promising Cancer Research at ASCO 2024

    Eisai Unveils Promising Cancer Research at ASCO 2024

    5/23/2024

  • Revolutionary Approach for Treating Immune Disorders Unveiled at 2024 BIO International

    Revolutionary Approach for Treating Immune Disorders Unveiled at 2024 BIO International

    5/23/2024

  • FDA Approves Phase III Trial, Offering New Hope for Advanced Prostate Cancer Patients

    FDA Approves Phase III Trial, Offering New Hope for Advanced Prostate Cancer Patients

    5/23/2024

  • Localized Drug Delivery: A New Hope for Fighting KRAS+ Tumors

    Localized Drug Delivery: A New Hope for Fighting KRAS+ Tumors

    5/23/2024

  • Servier's Bold Move Against Cancer: New Findings at ASCO 2024

    Servier's Bold Move Against Cancer: New Findings at ASCO 2024

    5/23/2024

  • Revolutionary Immune Therapy: Bionoxx's New Approach to Fighting Cancer

    Revolutionary Immune Therapy: Bionoxx's New Approach to Fighting Cancer

    5/23/2024

  • FDA Approves Advanced Digital Pathology Platform: HALO AP Dx

    FDA Approves Advanced Digital Pathology Platform: HALO AP Dx

    5/23/2024

  • New Hope in Cancer Vaccines for Treating Melanoma and Other Solid Tumors

    New Hope in Cancer Vaccines for Treating Melanoma and Other Solid Tumors

    5/23/2024

  • New Immunotherapy Combinations Bring Hope in Bladder Cancer Treatment

    New Immunotherapy Combinations Bring Hope in Bladder Cancer Treatment

    5/22/2024

  • New Horizons in Myelofibrosis Treatment: The Promise of JAK Inhibitor Combinations

    New Horizons in Myelofibrosis Treatment: The Promise of JAK Inhibitor Combinations

    5/22/2024

  • New Biosimilars for Bone Disorders Approved in Europe

    New Biosimilars for Bone Disorders Approved in Europe

    5/22/2024

  • Guardant360 CDx: A Breakthrough in Tumor Profiling and Personalized Cancer Treatment

    Guardant360 CDx: A Breakthrough in Tumor Profiling and Personalized Cancer Treatment

    5/22/2024

  • Exciting Advances in Treating Leukemia with CAR T-Cell Therapy

    Exciting Advances in Treating Leukemia with CAR T-Cell Therapy

    5/22/2024

  • Why HPV Testing Every 5 Years is Safe and Effective

    Why HPV Testing Every 5 Years is Safe and Effective

    5/22/2024

  • How Tumor Mutations Influence Kidney Cancer Treatment Outcomes

    How Tumor Mutations Influence Kidney Cancer Treatment Outcomes

    5/22/2024

  • Understanding New Treatment Options for Myelofibrosis: JAK Inhibitors

    Understanding New Treatment Options for Myelofibrosis: JAK Inhibitors

    5/21/2024

  • Understanding the Role of TIBs in Metastatic Kidney Cancer Treatments

    Understanding the Role of TIBs in Metastatic Kidney Cancer Treatments

    5/21/2024

  • New Treatment Approach Shows Promise for Advanced Rectal Cancer

    New Treatment Approach Shows Promise for Advanced Rectal Cancer

    5/21/2024

  • Celebrating Trailblazing Women in Cancer Care at ASCO Annual Meeting

    Celebrating Trailblazing Women in Cancer Care at ASCO Annual Meeting

    5/21/2024

  • Promising New Treatment for Pancreatic Cancer: Azeliragon Gains Important FDA Status

    Promising New Treatment for Pancreatic Cancer: Azeliragon Gains Important FDA Status

    5/21/2024

  • Beta-Blockers Not Effective in Reducing Anxiety Among Cancer Survivors

    Beta-Blockers Not Effective in Reducing Anxiety Among Cancer Survivors

    5/21/2024

  • New Breakthrough Therapy for Breast Cancer: Inavolisib Impresses FDA

    New Breakthrough Therapy for Breast Cancer: Inavolisib Impresses FDA

    5/21/2024

  • New Cancer Drug Saruparib Shows Promise in Early Trials

    New Cancer Drug Saruparib Shows Promise in Early Trials

    5/21/2024

  • New Hope in Cancer Treatment: Subcutaneous Nivolumab Awaits Approval

    New Hope in Cancer Treatment: Subcutaneous Nivolumab Awaits Approval

    5/21/2024

  • New Hope for Head and Neck Cancer Patients: Tivumecirnon and Pembrolizumab Combo Shines

    New Hope for Head and Neck Cancer Patients: Tivumecirnon and Pembrolizumab Combo Shines

    5/20/2024

  • Adding Ibrutinib to Chemoimmunotherapy Boosts Success in Treating Younger Mantle Cell Lymphoma Patients

    Adding Ibrutinib to Chemoimmunotherapy Boosts Success in Treating Younger Mantle Cell Lymphoma Patients

    5/20/2024

  • Proton Therapy: A New Hope in Precision Cancer Treatment

    Proton Therapy: A New Hope in Precision Cancer Treatment

    5/20/2024

  • Promising BTK Inhibitor Combos Shine in CLL Treatment: New Insights

    Promising BTK Inhibitor Combos Shine in CLL Treatment: New Insights

    5/20/2024

  • Celebrating Excellence in Nutrition: Kara Stromberg's Keystone Award

    Celebrating Excellence in Nutrition: Kara Stromberg's Keystone Award

    5/20/2024

  • Breakthrough CAR-T Therapy WU-CART-007 Shows Promise for Blood Cancer Patients

    Breakthrough CAR-T Therapy WU-CART-007 Shows Promise for Blood Cancer Patients

    5/20/2024

  • New Cancer Drug Combo Offers Hope for Hard-to-Treat Endometrial Cancer

    New Cancer Drug Combo Offers Hope for Hard-to-Treat Endometrial Cancer

    5/20/2024

  • FDA Halts Approval of Infigratinib for Rare Liver Cancer Treatment

    FDA Halts Approval of Infigratinib for Rare Liver Cancer Treatment

    5/20/2024

  • New Insights into HER2+ Breast Cancer Treatments Revealed by Real-World Study

    New Insights into HER2+ Breast Cancer Treatments Revealed by Real-World Study

    5/19/2024

  • Young Women Facing Increased Risk of Colorectal Cancer

    Young Women Facing Increased Risk of Colorectal Cancer

    5/19/2024

  • Promising Combination Therapy for Endometrial Cancer Shows Extended Survival Rates

    Promising Combination Therapy for Endometrial Cancer Shows Extended Survival Rates

    5/18/2024

  • Rotaxane Actuators: A Breakthrough in Efficient Drug Delivery

    Rotaxane Actuators: A Breakthrough in Efficient Drug Delivery

    5/18/2024

  • Addressing Cancer Inequities: The Latest AACR Insights

    Addressing Cancer Inequities: The Latest AACR Insights

    5/18/2024

  • Fertility Treatment Found Safe for Breast Cancer Survivors with BRCA Mutations

    Fertility Treatment Found Safe for Breast Cancer Survivors with BRCA Mutations

    5/18/2024

  • New Hope for Lung Cancer Patients: FDA Grants Special Status to NVL-655

    New Hope for Lung Cancer Patients: FDA Grants Special Status to NVL-655

    5/17/2024

  • New Insights on Lenvatinib/Pembrolizumab Combo for Advanced Endometrial Cancer

    New Insights on Lenvatinib/Pembrolizumab Combo for Advanced Endometrial Cancer

    5/17/2024

  • Timing of Radiation Therapy Crucial for Urinary Sphincter Success in Prostate Cancer Patients

    Timing of Radiation Therapy Crucial for Urinary Sphincter Success in Prostate Cancer Patients

    5/17/2024

  • Genital Talc Linked to Higher Risk of Ovarian Cancer, New Study Finds

    Genital Talc Linked to Higher Risk of Ovarian Cancer, New Study Finds

    5/17/2024

  • Childhood Body Size Linked to Lower Breast Cancer Risk in Adulthood

    Childhood Body Size Linked to Lower Breast Cancer Risk in Adulthood

    5/16/2024

  • New Hope for Advanced Lung Cancer Patients: FDA Approves Tarlatamab

    New Hope for Advanced Lung Cancer Patients: FDA Approves Tarlatamab

    5/16/2024

  • New Treatment Offers Hope for Advanced Breast Cancer Patients

    New Treatment Offers Hope for Advanced Breast Cancer Patients

    5/16/2024

  • FDA Approves At-Home HPV Test to Boost Cervical Cancer Screening

    FDA Approves At-Home HPV Test to Boost Cervical Cancer Screening

    5/16/2024

  • FDA Gives Green Light to New Treatment for Resistant Follicular Lymphoma

    FDA Gives Green Light to New Treatment for Resistant Follicular Lymphoma

    5/16/2024

  • Atezolizumab Fails to Extend Survival in Early-Relapsing TNBC

    Atezolizumab Fails to Extend Survival in Early-Relapsing TNBC

    5/16/2024

  • Promising Combo Treatment for Biliary Tract Cancer Shows Positive Results

    Promising Combo Treatment for Biliary Tract Cancer Shows Positive Results

    5/15/2024

  • Neighborhood Conditions Impact Breast Cancer Survival Rates

    Neighborhood Conditions Impact Breast Cancer Survival Rates

    5/15/2024

  • New Insights from PROSPECT Trial on Rectal Cancer Treatment Options

    New Insights from PROSPECT Trial on Rectal Cancer Treatment Options

    5/15/2024

  • New Gene Therapy Brings Hope for Bladder Cancer Treatment

    New Gene Therapy Brings Hope for Bladder Cancer Treatment

    5/15/2024

  • Innovative Immunotherapy Approaches Transform Urothelial Cancer Treatment

    Innovative Immunotherapy Approaches Transform Urothelial Cancer Treatment

    5/15/2024

  • Increased Mortality and Complications for Cancer Surgeries During COVID-19

    Increased Mortality and Complications for Cancer Surgeries During COVID-19

    5/15/2024

  • FDA Greenlights New Drug Trial for Advanced B-Cell Non-Hodgkin Lymphomas

    FDA Greenlights New Drug Trial for Advanced B-Cell Non-Hodgkin Lymphomas

    5/14/2024

  • New Hope for Multiple Myeloma: Bispecific T-Cell Therapies Show Promise

    New Hope for Multiple Myeloma: Bispecific T-Cell Therapies Show Promise

    5/14/2024

  • FDA Approves Groundbreaking Trial: SynKIR-310 for Tough-to-Treat B-cell NHL

    FDA Approves Groundbreaking Trial: SynKIR-310 for Tough-to-Treat B-cell NHL

    5/14/2024

  • Revolutionary Test MyProstateScore 2.0 Enhances Prostate Cancer Detection Accuracy

    Revolutionary Test MyProstateScore 2.0 Enhances Prostate Cancer Detection Accuracy

    5/14/2024

  • How a Plant-Based Diet Could Help Fight Prostate Cancer Progression

    How a Plant-Based Diet Could Help Fight Prostate Cancer Progression

    5/13/2024

  • Promising Outcomes of Nivolumab and Ipilimumab Combo in Treating Advanced Cervical Cancer

    Promising Outcomes of Nivolumab and Ipilimumab Combo in Treating Advanced Cervical Cancer

    5/13/2024

  • Understanding the Impact of Metabolic Syndrome and Obesity on Breast Cancer Risks in Postmenopausal Women

    Understanding the Impact of Metabolic Syndrome and Obesity on Breast Cancer Risks in Postmenopausal Women

    5/13/2024

  • Increasing Participation in Cancer Trials: A New Insight

    Increasing Participation in Cancer Trials: A New Insight

    5/13/2024

  • Promising Immunotherapy Combinations Show Positive Results for Cervical Cancer

    Promising Immunotherapy Combinations Show Positive Results for Cervical Cancer

    5/13/2024

  • Understanding Melanoma in Diverse Populations: A Critical Study on Race and Gender

    Understanding Melanoma in Diverse Populations: A Critical Study on Race and Gender

    5/13/2024

  • Setback in Melanoma Research: Termination of Promising Drug Combo Study

    Setback in Melanoma Research: Termination of Promising Drug Combo Study

    5/13/2024

  • Setback for Merck as High-Risk Melanoma Treatment Trial Halts Due to Futility Criteria

    Setback for Merck as High-Risk Melanoma Treatment Trial Halts Due to Futility Criteria

    5/13/2024

  • Setback in Advanced Lung Cancer Treatment: Recent Clinical Trial Results

    Setback in Advanced Lung Cancer Treatment: Recent Clinical Trial Results

    5/13/2024

  • Accelerating Hope: FDA Fast Tracks Promising New Treatment for Small Cell Lung Cancer

    Accelerating Hope: FDA Fast Tracks Promising New Treatment for Small Cell Lung Cancer

    5/13/2024

  • Emerging Therapies in Low-Grade Serous Ovarian Cancer: Focus on Avutometinib and Defactinib

    Emerging Therapies in Low-Grade Serous Ovarian Cancer: Focus on Avutometinib and Defactinib

    5/13/2024

  • Revolutionizing Gastric Cancer Detection: Non-Invasive Oral Microbiome Testing

    Revolutionizing Gastric Cancer Detection: Non-Invasive Oral Microbiome Testing

    5/13/2024

  • Revolutionizing Prostate Cancer Treatment: The Promise of 177Lutetium-PSMA-617 in Community Oncology

    Revolutionizing Prostate Cancer Treatment: The Promise of 177Lutetium-PSMA-617 in Community Oncology

    5/13/2024

  • Exploring Lifileucel Therapy in Advanced Lung Cancer

    Exploring Lifileucel Therapy in Advanced Lung Cancer

    5/13/2024

  • Exploring New Horizons in Graft-vs-Host Disease Management and Research

    Exploring New Horizons in Graft-vs-Host Disease Management and Research

    5/12/2024

  • New Frontiers in Cancer Treatment: FDA Greenlights WGc-043 mRNA Vaccine for Clinical Trials

    New Frontiers in Cancer Treatment: FDA Greenlights WGc-043 mRNA Vaccine for Clinical Trials

    5/12/2024

  • Exploring the Impact of Federal Funding Shifts on Cancer Research

    Exploring the Impact of Federal Funding Shifts on Cancer Research

    5/11/2024

  • Advancements in Bladder Cancer Treatment: Nivolumab and Nab-Paclitaxel Combination Proves Promising

    Advancements in Bladder Cancer Treatment: Nivolumab and Nab-Paclitaxel Combination Proves Promising

    5/11/2024

  • Exploring Advanced Lung Cancer Treatment: New Insights from the CheckMate73L Trial

    Exploring Advanced Lung Cancer Treatment: New Insights from the CheckMate73L Trial

    5/11/2024

  • Breakthrough in Cancer Treatment: FDA Greenlights Clinical Trials for New Epstein-Barr mRNA Vaccine

    Breakthrough in Cancer Treatment: FDA Greenlights Clinical Trials for New Epstein-Barr mRNA Vaccine

    5/11/2024

  • Innovative Nivolumab Therapy Shows Promise in Treating Advanced Uterine and Ovarian Cancer

    Innovative Nivolumab Therapy Shows Promise in Treating Advanced Uterine and Ovarian Cancer

    5/11/2024

  • Navigating the Challenges of Cancer Research Funding in the Current Economic Climate

    Navigating the Challenges of Cancer Research Funding in the Current Economic Climate

    5/11/2024

  • Enhancing Diversity in Surgical Oncology Research: Insights from Miami's Minority Breast Cancer Patients

    Enhancing Diversity in Surgical Oncology Research: Insights from Miami's Minority Breast Cancer Patients

    5/11/2024

  • Advancing Endometrial Cancer Treatment: Dana-Farber's New Research Initiative

    Advancing Endometrial Cancer Treatment: Dana-Farber's New Research Initiative

    5/11/2024

...
0
Terms & Conditions
Privacy Policy
MDPile